Why are so few antipsychotic drugs licensed for Alzheimer's disease related behavioral and psychological symptoms?

Calsolaro, Valeria; Antognoli, Rachele; Monzani, Fabio

Calsolaro, Valeria; Antognoli, Rachele; Monzani, Fabio.

Afiliação

Calsolaro V; Geriatrics Unit, Department of Clinical & Experimental Medicine, University of Pisa , Pisa , Italy.
Antognoli R; Neurology Imaging Unit, Imperial College , London , UK.
Monzani F; Geriatrics Unit, Department of Clinical & Experimental Medicine, University of Pisa , Pisa , Italy.

Expert Rev Neurother ; 19(11): 1051-1053, 2019 11.

Article em En | MEDLINE | ID: mdl-31282774

Palavras-chave

Alzheimer's disease; antipsychotic drugs; behavioral and psychological symptoms; nonpharmacological therapy; pharmacological therapy; safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Expert Rev Neurother Assunto da revista: NEUROLOGIA / TERAPEUTICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google